2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)
作者： L. Samuel Wann , Anne B. Curtis , Kenneth A. Ellenbogen , N.A. Mark Estes , Michael D. Ezekowitz
DOI: 10.1161/CIR.0B013E31820F14C0
关键词:
摘要: 2011;57;1330-1337; originally published online Feb 14, 2011; J. Am. Coll. Cardiol. Richard L. Page, David Slotwiner, William G. Stevenson, and Cynthia M. Tracy Michael D. Ezekowitz, Warren Jackman, Craig T. January, James E. Lowe, Samuel Wann, Anne B. Curtis, Kenneth A. Ellenbogen, N.A. Mark Estes, III, on Practice Guidelines of Cardiology Foundation Foundation/American Heart Association Task Force Atrial Fibrillation (Update Dabigatran): A Report the American College 2011 ACCF/AHA/HRS Focused Update Management Patients With This information is current as March 11, 2012 http://content.onlinejacc.org/cgi/content/full/57/11/1330 located World Wide Web at: The version this article, along with updated services,
arritmiaonline.com.br 
sci-hub.se 参考文章(5)
Stuart J Connolly, Michael D Ezekowitz, Salim Yusuf, Paul A Reilly, Lars Wallentin, None, Newly identified events in the RE-LY trial. The New England Journal of Medicine. ,vol. 363, pp. 1875- 1876 ,(2010) , 10.1056/NEJMC1007378
Brian F. Gage, Can We Rely on RE-LY? New England Journal of Medicine. ,vol. 361, pp. 1200- 1202 ,(2009) , 10.1056/NEJME0906886
Lars Wallentin, Robert G Wilcox, W Douglas Weaver, Håkan Emanuelsson, Andrew Goodvin, Per Nyström, Anders Bylock, Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial The Lancet. ,vol. 362, pp. 789- 797 ,(2003) , 10.1016/S0140-6736(03)14287-0
Stuart J Connolly, Michael D Ezekowitz, Salim Yusuf, John Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul A Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Diaz, Basil S Lewis, Harald Darius, Hans-Christoph Diener, Campbell D Joyner, Lars Wallentin, RE-LY Steering Committee and Investigators, None, Dabigatran versus Warfarin in Patients with Atrial Fibrillation New England Journal of Medicine. ,vol. 361, pp. 1139- 1151 ,(2009) , 10.1056/NEJMOA0905561
Veronica Dean, Jaap W. Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano, , , Valentin Fuster, Lars E. Rydén, David S. Cannom, Harry J. Crijns, Anne B. Curtis, Kenneth A. Ellenbogen, Jonathan L. Halperin, Jean-Yves Le Heuzey, G. Neal Kay, James E. Lowe, S. Bertil Olsson, Eric N. Prystowsky, Juan Luis Tamargo, Samuel Wann, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffery L. Anderson, Elliott M. Antman, Jonathan L. Halperin, Sharon Ann Hunt, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Silvia G. Priori, Jean-Jacques Blanc, Andrzej Budaj, A. John Camm, ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation. ,vol. 114, pp. 257- 354 ,(2006) , 10.1161/CIRCULATIONAHA.106.177292